AI
CNTA

Atom Investors’s Centessa Pharmaceuticals CNTA Stock Holding History

Atom Investors’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.3M Buy
158,509
+140,162
+764% +$3.59M 0.45% 48
2025
Q4 		$459K Buy
+18,347
New +$465K 0.04% 396
2025
Q1 		– Sell
-17,197
Closed -$288K – 529
2024
Q4 		$288K Buy
+17,197
New +$285K 0.04% 386

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Atom Investors's CNTA Position: Q1 2026 in Review

Atom Investors increased its Centessa Pharmaceuticals (CNTA) stake by 764% in Q1 2026, buying an estimated $3.59M and bringing the position to 158,509 shares worth $6.3M. The position accounts for 0.45% of the portfolio, ranked #48.

Atom Investors first reported a position in CNTA in Q4 2024 and has held it in 3 quarters since. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Atom Investors held 158,509 shares of Centessa Pharmaceuticals worth $6.3M as of Q1 2026.
  • Atom Investors bought 140,162 Centessa Pharmaceuticals shares in Q1 2026, an estimated $3.59M.
  • Centessa Pharmaceuticals made up 0.45% of Atom Investors's portfolio in Q1 2026, its #48 holding.
  • Atom Investors first reported a position in Centessa Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.